Phase II Study of AP0302 5% Versus a Vehicle Comparator

PHASE2CompletedINTERVENTIONAL
Enrollment

147

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

June 30, 2016

Conditions
PainDelayed Onset Muscle Soreness
Interventions
DRUG

S-Ibuprofen Topical Gel 5%

S-Ibuprofen Topical Gel 5% applied every 6 hours

DRUG

Vehicle Topical Gel

Vehicle Topical Gel applied every 6 hours

Trial Locations (1)

91105

Lotus Clinical Research, LLC, Pasadena

Sponsors
All Listed Sponsors
lead

Aponia Laboratories, Inc.

INDUSTRY

NCT02324985 - Phase II Study of AP0302 5% Versus a Vehicle Comparator | Biotech Hunter | Biotech Hunter